Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PMA de la FDA

Automated insulin dosing device system, single hormonal control

Número de PMA: P160017 · 2026-08-05

SolicitanteMedtronic Minimed, Inc.
Fecha de decisión2026-08-05
Número PMAP160017
Código de productoOZP
Clase del dispositivoClase 3
Especialidad médicaU
Comité asesorCH

Resumen del dispositivo

Automated insulin dosing device system, single hormonal control is the device name listed in this FDA 510(k) record. The listed applicant is Medtronic Minimed, Inc.. It received FDA 510(k) clearance on 2026-08-05. The device is classified under product code OZP. It was reviewed by the CH advisory panel.

Preguntas frecuentes

What is the Automated insulin dosing device system, single hormonal control?

Automated insulin dosing device system, single hormonal control is a medical device that received FDA 510(k) clearance on 2026-08-05. The listed applicant is Medtronic Minimed, Inc..

When did Automated insulin dosing device system, single hormonal control receive FDA 510(k) clearance?

The clearance date for Automated insulin dosing device system, single hormonal control can be found in the official FDA records.

Who is the listed applicant for Automated insulin dosing device system, single hormonal control?

The FDA 510(k) record lists Medtronic Minimed, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Automated insulin dosing device system, single hormonal control?

The FDA product code for Automated insulin dosing device system, single hormonal control is OZP.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑